The shifting balance between CLU forms during tumor progression

Advances in Cancer Research

Volumn 104, Issue 1, 2009, Pages 25-32

  Pucci, Sabina ^a   Bettuzzi, Saverio ^b,c  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b Biochimica Clinica e Biochimica dell'Esercizio Fisico   (Italy)

^c NATIONAL INSTITUTE OF BIOSTRUCTURES AND BIOSYSTEMS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CLUSTERIN;

ANIMAL; CELL TRANSFORMATION; DISEASE COURSE; GENETICS; HUMAN; METABOLISM; NEOPLASM; REVIEW;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CLUSTERIN; DISEASE PROGRESSION; HUMANS; NEOPLASMS;

EID: 73949093466     PISSN: 0065230X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-230X(09)04003-2     Document Type: Review

References (17)

1. Bettuzzi, S., Scaltriti, M., Caporali, A., Brausi, M., D'Arca, D., Astancolle, S., Davalli, P., and Corti, A. (2003). Successful prediction of prostate cancer recurrence by gene profiling in combination with clinical data: A 5 years follow-up study. Cancer Res. 63, 3469-3472.
2. Bremer, J. (1997). The role of carnitine in cell metabolism. In "Carnitine Today," (C. De Simone and G. Famularo, Eds.), pp. 1-37. Springer-Verlag, Heidelberg.
3. Caporali, A., Davalli, P., Astancolle, S., D'Arca, D., Brausi, M., Bettuzzi, S., and Corti, A. (2004). The chemopreventive action of catechins in the TRAMP mouse model of prostate carcinogenesis is accompanied by clusterin over-expression. Carcinogenesis 25, 2217-2224.
4. Mazzarelli, P., Pucci, S., Bonanno, E., Sesti, F., Calvani, M., and Spagnoli, L. G. (2007). Carnitine palmitoyltransferase I in human carcinomas: A novel role in histone deacetylation? Cancer Biol. Ther. 6, 1606-1613.
5. Menendez, J. A., Vellon, L., and Lupu, R. (2005a). Targeting fatty acid synthase-driven lipid rafts: A novel strategy to overcome trastuzumab resistance in breast cancer cells. Med. Hypotheses 64, 997-1001.
6. Menendez, J. A., Decker, J. P., and Lupu, R. (2005b). In support of fatty acid synthase (FAS) as a metabolic oncogene: Extracellular acidosis acts in an epigenetic fashion activating FAS gene expression in cancer cells. J. Cell. Biochem. 94(1), 1-4.
7. Migita, T., Ruiz, S., Fornari, A., Fiorentino, M., Priolo, C., Zadra, G., Inazuka, F., Grisanzio, C., Palescandolo, E., Shin, E., Fiore, C., Xie, W., et al. (2009). Fatty acid synthase: A metabolic enzyme and candidate oncogene in prostate cancer. J. Natl Cancer Inst. 101(7), 519-532.
8. Paumen, M. B., Ishida, Y., Muramatsu, M., Yamamoto, M., and Honjo, T. (1997). Inhibition of carnitine palmitoyltransferase I augments sphingolipid synthesis and palmitate-induced apoptosis. J. Biol. Chem. 272(6), 3324-3329.
9. Pizer, E. S., Pflug, B. R., Bova, G. S., Han, W. F., Udan, M. S., and Nelson, J. B. (2001). Increased fatty acid synthase as a therapeutic target in androgen-independent prostate cancer progression. Prostate 47(2), 102-110.
10. Pucci, S., Mazzarelli, P., Sesti, F., Boothmann, D. A., and Spagnoli, L. G. (2009). Interleukin-6 affects cell death escaping mechanisms acting on Bax-Ku70-Clusterin interactions in human colon cancer progression. Cell Cycle 8(3), 473-481.
11. Reed, J. C. (1994). Bcl-2 and the regulation of programmed cell death. J. Cell Biol. 124(1-2), 1-6.
12. Rossi, S., Graner, E., Febbo, P., Weinstein, L., Bhattacharya, N., Onody, T., Bubley, G., Balk, S., and Loda, M. (2003). Fatty acid synthase expression defines distinct molecular signatures in prostate cancer. Mol. Cancer Res. 1(10), 707-715.
13. Scaltriti, M., Belloni, L., Caporali, A., Davalli, P., Remondini, D., Rizzi, F., Astancolle, S., Corti, A., and Bettuzzi, S. (2006). Molecular classification of green tea catechins-sensitive and -resistant prostate cancer in the TRAMP mice modelby quantitative real-time PCR gene profiling. Carcinogenesis 27, 1047-1053.
14. Shaw, R. J. (2006). Glucose metabolism and cancer. Curr. Opin. Cell Biol. 18, 598-608.
15. Wang, H. Q., Altomare, D. A., Skele, K. L., Poulikakos, P. I., Kuhajda, F. P., Di Cristofano, A., and Testa, J. R. (2005). Positive feedback regulation between AKT activation and fatty acid synthase expression in ovarian carcinoma cells. Oncogene 24(22), 3574-3582.
16. Weis, B. C., Esser, V., Foster, D.W., and McGarry, J. D. (1994). Rat heart expresses two forms of mitochondrial carnitine palmitoyltransferase I. The minor component is identical to the liver enzyme. J. Biol. Chem. 269, 18712-18715.
17. Zhang, S. Y., Ma, X. F., Zheng, C. G., Wang, Y., Cao, X. L., and Tian, W. X. (2008). Novel and potent inhibitors of fatty acid synthase derived from catechins and their inhibition on MCF-7 cell. J. Enzyme Inhib. Med. Chem. 1, 1.